Investing.com - Hookipa Pharma (NASDAQ:HOOK) reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Hookipa Pharma announced earnings per share of $-0.250 on revenue of $2.23M. Analysts polled by Investing.com anticipated EPS of $-0.271 on revenue of $2.86M.
Hookipa Pharma shares are down 45% from the beginning of the year, still down 71.75% from its 52 week high of $4.16 set on November 15, 2021.
Hookipa Pharma shares lost 6.00% in intra-day trade following the report.
Hookipa Pharma follows other major Healthcare sector earnings this month
Hookipa Pharma's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar